Investigator's Choice Treatment

DRUG2 trials

Sponsors

Shanghai Runshi Pharmaceutical Technology Co., Ltd

Conditions

High Grade MeningiomaRecurrent or Progressive High Grade Meningioma

Phase 2

A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade Meningioma

Not yet recruitingNCT06739213

Shanghai Runshi Pharmaceutical Technology Co., LtdRecurrent or Progressive High Grade Meningioma

Start: 2025-01-31End: 2028-01-13Target: 56Updated: 2024-12-18

Phase 3

A Phase III Study of SYHA1813 for Recurrent or Progressive High-Grade Meningiomas

Not yet recruitingNCT07613450

Shanghai Runshi Pharmaceutical Technology Co., LtdHigh Grade Meningioma

Start: 2026-05-20End: 2029-10-15Target: 136Updated: 2026-05-29